2026 Medicare ACO Initiatives: New Models, Increased Participation, and Enhanced Patient Care
The 2026 Medicare ACO landscape features expanded participation, new models like LEAD, and a focus on advanced payment tracks
2026
Read More
Baldness Biotech Veradermics Prices $256M IPO for Pivotal Tests of Pill for Hair Loss
Veradermics’s drug, a pill version of the topical hair loss product minoxidil, was developed with technology intended to avoid the cardiovascular risks associated with oral dosing of this compound. The first of three pivotal clinical trials is expected to yield preliminary data in the first half of 2026. The post Baldness Biotech Veradermics Prices $256M…
How Should Health System IT Leaders Respond to ‘Shadow AI’?
Wolters Kluwer Health CTO Alex Tyrrell discusses survey results that raise governance, patient safety and data security issues
Digital Health’s Latest Unicorn: Why Investors Are Backing Midi’s Model for Women’s Health
Virtual women’s health provider Midi Health has reached unicorn status after raising a $100 million Series D, with investors backing its insurance-covered, direct-to-consumer model. The company is positioning itself as a long-term, virtual “hospital without walls” designed to meet women’s health needs across midlife and beyond. The post Digital Health’s Latest Unicorn: Why Investors Are…
Cancer Detection Startup Secures $4M to Expand Access in Underserved Communities
beHuman’s $4 million seed round was led by Santé Ventures, with participation from DHVP.io. It will help expand its footprint. The post Cancer Detection Startup Secures $4M to Expand Access in Underserved Communities appeared first on MedCity News.
The $25.7B Healthcare Problem AI Is Finally Solving
Billing frustration isn’t just a provider problem; it’s a patient problem too. Every delayed claim, every error, every confusing denial ultimately affects the person receiving care. Now AI can reduce that friction. The post The $25.7B Healthcare Problem AI Is Finally Solving appeared first on MedCity News.
PGx Testing: Specialists Benefit From, and Build Upon Oncology’s Success
Some specialties, like oncology, have been quicker to embrace the promise of pharmacogenomics (PGx), and their successes can serve as a roadmap as others explore the impact it can have on quality, outcomes and patient satisfaction. The post PGx Testing: Specialists Benefit From, and Build Upon Oncology’s Success appeared first on MedCity News.
When the Doctor Needs a Checkup
He was a surgical oncologist at a hospital in a Southern city, a 78-year-old whose colleagues had begun noticing troubling behavior in the operating room. During procedures, he seemed “hesitant, not sure of how to go on to the next step without being prompted” by assistants, said Mark Katlic, director of the Aging Surgeon Program…
Listen: Many Tents Are Gone, but Washington’s Homeless — And Their Health Problems — Aren’t
LISTEN: In this audio portrait of homeless people displaced by the Trump administration’s crackdown on encampments in the nation’s capital, KFF Health News senior correspondent Angela Hart tells of residents living outside this winter and their search for medical care and shelter. January’s extreme cold has put a spotlight on the conditions homeless people face….
Will HHS Enhance or Stall the Promise of Artificial Intelligence for Healthcare?
By STEVEN ZECOLA In its Strategy for Artificial Intelligence (V.3), the Department of Health and Human Services (“HHS”) acknowledges that: “For too long, our Department has been bogged down by bureaucracy and busy work.” HHS promises that it will accelerate artificial intelligence (“AI”) innovation, including “accelerating drug and biologic approvals at the FDA.” History shows…